Cargando…
Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
BACKGROUND: Targeting higher hemoglobin levels with erythropoietin to treat anemia in patients with chronic kidney disease is associated with increased cardiovascular risk, including that of stroke. The risks of the subtypes of stroke, ischemic, hemorrhagic, and unspecified, following the administra...
Autores principales: | Hung, Peir‐Haur, Yeh, Chih‐Ching, Hsiao, Chih‐Yen, Muo, Chih‐Hsin, Hung, Kuan‐Yu, Tsai, Kuen‐Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483460/ https://www.ncbi.nlm.nih.gov/pubmed/34176302 http://dx.doi.org/10.1161/JAHA.120.019529 |
Ejemplares similares
-
Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019) -
The Association of Erythropoietin and Age-Related Macular Degeneration in Hemodialysis Patients: A Nationwide Population-Based Cohort Study
por: Huang, Evelyn-Jou-Chen, et al.
Publicado: (2022) -
End stage renal disease is associated with development of dementia
por: Hung, Peir-Haur, et al.
Publicado: (2017) -
Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan
por: Hsu, Yueh-Han, et al.
Publicado: (2015) -
Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2020)